Quick Answer
Silexion Therapeutics Corp reported Total Assets of $7.21 million for fiscal year 2025.
Silexion Therapeutics Corp Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $7.21M | +152.0% |
| 2024 | $2.86M | -45.5% |
| 2023 | $5.26M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $11.61M | +276.2% | +100.3% |
| June 30, 2025 | $5.80M | +150.4% | -30.2% |
| March 31, 2025 | $8.31M | +131.7% | +190.2% |
| December 31, 2024 | $2.86M | -45.5% | -7.3% |
| September 30, 2024 | $3.09M | — | +33.3% |
| June 30, 2024 | $2.31M | — | -35.4% |
| March 31, 2024 | $3.58M | — | -31.8% |
| December 31, 2023 | $5.26M | — | — |
- Silexion Therapeutics Corp showed an increase of +152.0% in Total Assets compared to the prior fiscal year.
- Over the 2023–2025 period, Silexion Therapeutics Corp’s total assets has grown by 37.3% (from $5.26 million to $7.21 million).
- The most recent figure is from Silexion Therapeutics Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: